西藏药业：目前新活素已覆盖医疗机构近7000家

Core Viewpoint - The pharmaceutical industry is characterized as a policy-driven sector, with product sales influenced by various factors including macroeconomic conditions, industry policies, and market environment changes [1] Group 1: Company Developments - The company reported that its product, New活素, has reached nearly 7,000 medical institutions [1] - The company plans to enhance collaboration with commercial companies to develop new hospitals and expand the coverage of New活素 [1] - The company has initiated exploratory research in evidence-based medicine for New活素 to further boost sales [1] Group 2: Sales Strategy - The company aims to maintain steady sales of New活素 through a series of measures, including academic promotion [1]